2024-11-09 10:37:28
2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab
Corporate/ 2023-07-23
2019 CSCO | CStone announces preliminary...

SUZHOU,China,Sept. 22,2019--CStone Pharmaceuticals ("CStone" or the "Company",HKEX: 2616) today announced preliminary re...

2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors
Corporate/ 2023-07-23
2019 CSCO| CStone announces promising OR...

SUZHOU,China,Sept. 22,2019-- CStone Pharmaceuticals ("CStone" or the "Company",HKEX: 2616) today announced results from ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release